Antithrombin for the prevention and therapy of vasculoproliferative disorders

Details for Australian Patent Application No. 2002313379 (hide)

Owner Aventis Behring GmbH

Inventors Hoelschermann, Hans; Stauss, Harald; Roemisch, Juergen

Agent Watermark

Pub. Number AU-A-2002313379

Priority 10159 556.5 05.12.01 DE

Filing date 4 December 2002

Wipo publication date 19 June 2003

International Classifications

A61K 038/36 Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61P 011/00 Drugs for disorders of the respiratory system

A61P 009/00 Drugs for disorders of the cardiovascular system

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 10159 556.5 05.12.01 DE

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002313379

17 March 2005 Change of Name(s) of Applicant(s), Section 104

  Aventis Behring GmbH The name of the applicant has been changed to ZLB Behring GmbH

4 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002313380-UV Inhibitors in HVAC Plastic Containers

2002313378-Building frame member and brace